Open-label, Exploratory Study of the Efficacy of Repetitive Transcranial Magnetic Stimulation on Naming and Verbal Fluency in Patients With Alzheimer's ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2008-2012

ABSTRACT

The investigators wish to investigate the efficacy of targeted repetitive transcranial magnetic stimulation (rTMS) on expressive language in patients with Alzheimer's disease (AD). In rTMS, magnetic pulses are used to noninvasively stimulate focal areas of cortex of about a square centimeter in area. rTMS has been approved in the United States for the diagnosis of peripheral nerve conditions. Depending on the frequency of stimulation, rTMS can preferentially stimulate or inhibit cortical areas. In stroke rehabilitation, for example, inhibition of the contralateral, uninvolved hemisphere by low frequency rTMS has improved movement of the affected limbs because of less aberrant inhibition of the affected hemisphere by the healthy hemisphere. The effects of rTMS has also been investigated and found to be useful in treating refractory depression and depression in Parkinson's disease. In addition, rTMS has improved naming in patients with Alzheimer's disease and has improved cognitive abilities and memory in non-demented older adults. Two studies found that rTMS improved aphasia in patients with stroke. While these studies are small, a review of the literature suggests that there may be a beneficial role for rTMS in patients with chronic neurological conditions. In addition, rTMS appears to be well tolerated, with transient headaches being the most common side effect. In this small open label study, the investigators wish to investigate the usefulness of bilateral stimulation of the brain region termed the dorsolateral prefrontal cortex (DLPFC) in patients with AD who have naming and language deficits. Detailed Description Subjects for this study will be recruited from Dr. Devi's clinical practice. Eligible subjects must have a diagnosis of possible or probable Alzheimer's disease using NINCDS-ADRDA criteria. The patient and his or her legally authorized representative need to be available to sign the informed consent. The assent of the incapable subject will be obtained prior to enrolling the subject in the study. Once informed consent and assent are obtained, the subject will have a functional magnetic resonance imaging (fMRI) scan of their brain anytime during the 2 weeks prior to the first study visit. At Visit 1, subjects will undergo a baseline battery of cognitive tests lasting approximately 30 minutes. Subsequently, the subject will undergo rTMS. During the visit, Dr. Devi will locate the area of the brain to be stimulated and mark that area of the scalp with an indelible skin marker that will wash out over time. In addition, the subjects will be provided with ear plugs to use during stimulation. This process of locating the area to be stimulated will take about an hour and will occur once. Then rTMS will be started and this procedure will take approximately 20-30 minutes (please see the full protocol for a complete description of this process). Each rTMS stimulation session will last for about 30 minutes, 2 consecutive days a week for 2 weeks. Both immediately prior to the onset of the first rTMS session, and just after the end of the fourth and final rTMS session, subjects will be tested on their cognitive and language skills. These two testing sessions will last 30 minutes each. Subjects will have another fMRI scan anytime during the 2 days after the fourth and final rTMS stimulation session. Subjects will continue to receive usual care throughout the study period. Any changes to usual treatment will be noted in the study file. All subjects will be seen again 4 weeks after the final study treatment session and will once again undergo the brief cognitive battery and fMRI scan. The investigators expect to recruit two subjects at a time for the study and each subject will be enrolled for 5 weeks from the baseline visit. More... »

URL

https://clinicaltrials.gov/show/NCT00814697

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3120", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3053", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "The investigators wish to investigate the efficacy of targeted repetitive transcranial magnetic stimulation (rTMS) on expressive language in patients with Alzheimer's disease (AD). In rTMS, magnetic pulses are used to noninvasively stimulate focal areas of cortex of about a square centimeter in area. rTMS has been approved in the United States for the diagnosis of peripheral nerve conditions. Depending on the frequency of stimulation, rTMS can preferentially stimulate or inhibit cortical areas. In stroke rehabilitation, for example, inhibition of the contralateral, uninvolved hemisphere by low frequency rTMS has improved movement of the affected limbs because of less aberrant inhibition of the affected hemisphere by the healthy hemisphere. The effects of rTMS has also been investigated and found to be useful in treating refractory depression and depression in Parkinson's disease. In addition, rTMS has improved naming in patients with Alzheimer's disease and has improved cognitive abilities and memory in non-demented older adults. Two studies found that rTMS improved aphasia in patients with stroke. While these studies are small, a review of the literature suggests that there may be a beneficial role for rTMS in patients with chronic neurological conditions. In addition, rTMS appears to be well tolerated, with transient headaches being the most common side effect. In this small open label study, the investigators wish to investigate the usefulness of bilateral stimulation of the brain region termed the dorsolateral prefrontal cortex (DLPFC) in patients with AD who have naming and language deficits.\n\nDetailed Description\nSubjects for this study will be recruited from Dr. Devi's clinical practice. Eligible subjects must have a diagnosis of possible or probable Alzheimer's disease using NINCDS-ADRDA criteria. The patient and his or her legally authorized representative need to be available to sign the informed consent. The assent of the incapable subject will be obtained prior to enrolling the subject in the study. Once informed consent and assent are obtained, the subject will have a functional magnetic resonance imaging (fMRI) scan of their brain anytime during the 2 weeks prior to the first study visit. At Visit 1, subjects will undergo a baseline battery of cognitive tests lasting approximately 30 minutes. Subsequently, the subject will undergo rTMS. During the visit, Dr. Devi will locate the area of the brain to be stimulated and mark that area of the scalp with an indelible skin marker that will wash out over time. In addition, the subjects will be provided with ear plugs to use during stimulation. This process of locating the area to be stimulated will take about an hour and will occur once. Then rTMS will be started and this procedure will take approximately 20-30 minutes (please see the full protocol for a complete description of this process). Each rTMS stimulation session will last for about 30 minutes, 2 consecutive days a week for 2 weeks. Both immediately prior to the onset of the first rTMS session, and just after the end of the fourth and final rTMS session, subjects will be tested on their cognitive and language skills. These two testing sessions will last 30 minutes each. Subjects will have another fMRI scan anytime during the 2 days after the fourth and final rTMS stimulation session. Subjects will continue to receive usual care throughout the study period. Any changes to usual treatment will be noted in the study file. All subjects will be seen again 4 weeks after the final study treatment session and will once again undergo the brief cognitive battery and fMRI scan. The investigators expect to recruit two subjects at a time for the study and each subject will be enrolled for 5 weeks from the baseline visit.", 
    "endDate": "2012-08-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT00814697", 
    "keywords": [
      "label", 
      "exploratory study", 
      "transcranial magnetic stimulation", 
      "naming", 
      "verbal fluency", 
      "Alzheimer Disease", 
      "functional imaging", 
      "efficacy", 
      "expressive language", 
      "patient", 
      "pulse", 
      "focal area", 
      "cortex", 
      "square centimeter", 
      "United State", 
      "diagnosis", 
      "peripheral nerve", 
      "frequency", 
      "stimulation", 
      "cortical area", 
      "stroke rehabilitation", 
      "inhibition", 
      "hemisphere", 
      "movement", 
      "affected limb", 
      "Treatment-Resistant Depressive Disorder", 
      "depression", 
      "Parkinson's", 
      "disease", 
      "Alzheimer's", 
      "cognitive ability", 
      "memory", 
      "old adult", 
      "stroke", 
      "review", 
      "beneficial role", 
      "neurological condition", 
      "headache", 
      "common side effect", 
      "usefulness", 
      "brain region", 
      "dorsolateral prefrontal cortex", 
      "language deficit", 
      "clinical practice", 
      "eligible subject", 
      "representative", 
      "informed consent", 
      "assent", 
      "Magnetic Resonance Imaging", 
      "brain", 
      "first study", 
      "baseline", 
      "cognitive test", 
      "visit", 
      "scalp", 
      "marker", 
      "wash", 
      "plug", 
      "method", 
      "protocol", 
      "complete description", 
      "onset", 
      "language skill", 
      "testing session", 
      "usual care", 
      "study period", 
      "usual treatment", 
      "treatment session", 
      "cognitive battery", 
      "baseline visit"
    ], 
    "name": "Open-label, Exploratory Study of the Efficacy of Repetitive Transcranial Magnetic Stimulation on Naming and Verbal Fluency in Patients With Alzheimer's Disease With Functional Imaging Correlates", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT00814697"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00006.json", 
    "startDate": "2008-12-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1007/s00702-010-0578-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020926842", 
          "https://doi.org/10.1007/s00702-010-0578-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00702-010-0578-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020926842", 
          "https://doi.org/10.1007/s00702-010-0578-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-011-6128-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040974259", 
          "https://doi.org/10.1007/s00415-011-6128-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/jnnp.2009.197848", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041631862"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1468-1331.2008.02202.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044360181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00702-012-0902-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046888162", 
          "https://doi.org/10.1007/s00702-012-0902-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00702-012-0902-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046888162", 
          "https://doi.org/10.1007/s00702-012-0902-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.63.11.1602", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051333275"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT00814697"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT00814697'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT00814697'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT00814697'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT00814697'


 

This table displays all metadata directly associated to this object as RDF triples.

111 TRIPLES      15 PREDICATES      91 URIs      79 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT00814697 schema:about anzsrc-for:3053
2 anzsrc-for:3120
3 schema:description The investigators wish to investigate the efficacy of targeted repetitive transcranial magnetic stimulation (rTMS) on expressive language in patients with Alzheimer's disease (AD). In rTMS, magnetic pulses are used to noninvasively stimulate focal areas of cortex of about a square centimeter in area. rTMS has been approved in the United States for the diagnosis of peripheral nerve conditions. Depending on the frequency of stimulation, rTMS can preferentially stimulate or inhibit cortical areas. In stroke rehabilitation, for example, inhibition of the contralateral, uninvolved hemisphere by low frequency rTMS has improved movement of the affected limbs because of less aberrant inhibition of the affected hemisphere by the healthy hemisphere. The effects of rTMS has also been investigated and found to be useful in treating refractory depression and depression in Parkinson's disease. In addition, rTMS has improved naming in patients with Alzheimer's disease and has improved cognitive abilities and memory in non-demented older adults. Two studies found that rTMS improved aphasia in patients with stroke. While these studies are small, a review of the literature suggests that there may be a beneficial role for rTMS in patients with chronic neurological conditions. In addition, rTMS appears to be well tolerated, with transient headaches being the most common side effect. In this small open label study, the investigators wish to investigate the usefulness of bilateral stimulation of the brain region termed the dorsolateral prefrontal cortex (DLPFC) in patients with AD who have naming and language deficits. Detailed Description Subjects for this study will be recruited from Dr. Devi's clinical practice. Eligible subjects must have a diagnosis of possible or probable Alzheimer's disease using NINCDS-ADRDA criteria. The patient and his or her legally authorized representative need to be available to sign the informed consent. The assent of the incapable subject will be obtained prior to enrolling the subject in the study. Once informed consent and assent are obtained, the subject will have a functional magnetic resonance imaging (fMRI) scan of their brain anytime during the 2 weeks prior to the first study visit. At Visit 1, subjects will undergo a baseline battery of cognitive tests lasting approximately 30 minutes. Subsequently, the subject will undergo rTMS. During the visit, Dr. Devi will locate the area of the brain to be stimulated and mark that area of the scalp with an indelible skin marker that will wash out over time. In addition, the subjects will be provided with ear plugs to use during stimulation. This process of locating the area to be stimulated will take about an hour and will occur once. Then rTMS will be started and this procedure will take approximately 20-30 minutes (please see the full protocol for a complete description of this process). Each rTMS stimulation session will last for about 30 minutes, 2 consecutive days a week for 2 weeks. Both immediately prior to the onset of the first rTMS session, and just after the end of the fourth and final rTMS session, subjects will be tested on their cognitive and language skills. These two testing sessions will last 30 minutes each. Subjects will have another fMRI scan anytime during the 2 days after the fourth and final rTMS stimulation session. Subjects will continue to receive usual care throughout the study period. Any changes to usual treatment will be noted in the study file. All subjects will be seen again 4 weeks after the final study treatment session and will once again undergo the brief cognitive battery and fMRI scan. The investigators expect to recruit two subjects at a time for the study and each subject will be enrolled for 5 weeks from the baseline visit.
4 schema:endDate 2012-08-01T00:00:00Z
5 schema:keywords Alzheimer Disease
6 Alzheimer's
7 Magnetic Resonance Imaging
8 Parkinson's
9 Treatment-Resistant Depressive Disorder
10 United State
11 affected limb
12 assent
13 baseline
14 baseline visit
15 beneficial role
16 brain
17 brain region
18 clinical practice
19 cognitive ability
20 cognitive battery
21 cognitive test
22 common side effect
23 complete description
24 cortex
25 cortical area
26 depression
27 diagnosis
28 disease
29 dorsolateral prefrontal cortex
30 efficacy
31 eligible subject
32 exploratory study
33 expressive language
34 first study
35 focal area
36 frequency
37 functional imaging
38 headache
39 hemisphere
40 informed consent
41 inhibition
42 label
43 language deficit
44 language skill
45 marker
46 memory
47 method
48 movement
49 naming
50 neurological condition
51 old adult
52 onset
53 patient
54 peripheral nerve
55 plug
56 protocol
57 pulse
58 representative
59 review
60 scalp
61 square centimeter
62 stimulation
63 stroke
64 stroke rehabilitation
65 study period
66 testing session
67 transcranial magnetic stimulation
68 treatment session
69 usefulness
70 usual care
71 usual treatment
72 verbal fluency
73 visit
74 wash
75 schema:name Open-label, Exploratory Study of the Efficacy of Repetitive Transcranial Magnetic Stimulation on Naming and Verbal Fluency in Patients With Alzheimer's Disease With Functional Imaging Correlates
76 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT00814697
77 schema:sdDatePublished 2019-03-07T15:23
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher N4fe81c7e45c540f7b157405cd8df32c9
80 schema:startDate 2008-12-01T00:00:00Z
81 schema:subjectOf sg:pub.10.1007/s00415-011-6128-4
82 sg:pub.10.1007/s00702-010-0578-1
83 sg:pub.10.1007/s00702-012-0902-z
84 https://doi.org/10.1001/archneur.63.11.1602
85 https://doi.org/10.1111/j.1468-1331.2008.02202.x
86 https://doi.org/10.1136/jnnp.2009.197848
87 schema:url https://clinicaltrials.gov/show/NCT00814697
88 sgo:license sg:explorer/license/
89 sgo:sdDataset clinical_trials
90 rdf:type schema:MedicalStudy
91 N4fe81c7e45c540f7b157405cd8df32c9 schema:name Springer Nature - SN SciGraph project
92 rdf:type schema:Organization
93 anzsrc-for:3053 schema:inDefinedTermSet anzsrc-for:
94 rdf:type schema:DefinedTerm
95 anzsrc-for:3120 schema:inDefinedTermSet anzsrc-for:
96 rdf:type schema:DefinedTerm
97 sg:pub.10.1007/s00415-011-6128-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040974259
98 https://doi.org/10.1007/s00415-011-6128-4
99 rdf:type schema:CreativeWork
100 sg:pub.10.1007/s00702-010-0578-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020926842
101 https://doi.org/10.1007/s00702-010-0578-1
102 rdf:type schema:CreativeWork
103 sg:pub.10.1007/s00702-012-0902-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1046888162
104 https://doi.org/10.1007/s00702-012-0902-z
105 rdf:type schema:CreativeWork
106 https://doi.org/10.1001/archneur.63.11.1602 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051333275
107 rdf:type schema:CreativeWork
108 https://doi.org/10.1111/j.1468-1331.2008.02202.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1044360181
109 rdf:type schema:CreativeWork
110 https://doi.org/10.1136/jnnp.2009.197848 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041631862
111 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...